PedAM
Pediatric Disease Annotations & Medicines
| Disease | spasticity |
| Phenotype | |cerebral palsy |
| Sentences | 56 |
| PubMedID- 22207070 | Aim: the aim of this study was to evaluate the efficacy and safety of radial extracorporeal shock wave therapy (reswt) in the treatment of spasticity in patients with cerebral palsy. |
| PubMedID- 23603803 | Effect of radial shock wave therapy on muscle spasticity in children with cerebral palsy. |
| PubMedID- 23885344 | Tendon structure and extracellular matrix components are affected by spasticity in cerebral palsy patients. |
| PubMedID- 22069575 | Treatment of leg spasticity in children with cerebral palsy with bont means surgical lengthening of the heel cord to improve gait can be avoided [35,36]. |
| PubMedID- 20139400 | Baclofen is widely used to control spasticity in children with cerebral palsy. |
| PubMedID- 26482429 | In the spasticity group, patients with cerebral palsy, patients with lower motor neuron lesions, and those with cerebellar findings were excluded from the study. |
| PubMedID- 21624819 | Classification of topographical pattern of spasticity in cerebral palsy: a registry perspective. |
| PubMedID- 25755853 | Literature review: there are epidemiological, clinical and review studies about management of spasticity in children with cerebral palsy. |
| PubMedID- 23428186 | Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum a toxin. |
| PubMedID- 22641937 | According to the recommendations of the french health products safety agency (afssaps) in 2009, botulinum toxin injections are recommended to reduce spasticity in children with cerebral palsy. |
| PubMedID- 23112577 | There is adequate evidence for selective dorsal rhizotomy for spasticity in cerebral palsy. |
| PubMedID- 21800690 | Selective dorsal rhizotomy (sdr) is a surgical technique for reducing spasticity associated with cerebral palsy (cp). |
| PubMedID- 20602795 | Despite this reported sensitivity, the mts has demonstrated poor reliability as a measure of elbow flexor spasticity in children with cerebral palsy with large inter-sessional variation and difficulty in applying standardised velocities [64]. |
| PubMedID- 24235067 | Background: botulinum toxin a (btx-a) has been successfully used as a treatment for children with spastic cerebral palsy; however, the effect of btx-a on reducing spasticity only lasts a few months, thus serial injections are required. |
| PubMedID- 23175906 | Conclusion: personal care and mobility which are aspects of the health related quality of life should be paid more attention to, as they are negatively affected by spasticity in patients with cerebral palsy. |
| PubMedID- 21772975 | Human studies have reported potential benefits in bone [9–18], muscle function [15, 17, 19, 20], balance and prevention of falls [21], reduction of muscle spasticity in those with cerebral palsy [22], and postural control in those with parkinson's disease [23]. |
| PubMedID- 22256328 | Based on clinical data collected from children with cerebral palsy, four levels of elbow spasticity (1, 1+, 2, and 3 in the modified ashworth scale [mas]) were recreated by hess. |
| PubMedID- 24305054 | Baclofen, a selective gabab agonist, is used clinically to treat muscle spasticity associated with multiple sclerosis, cerebral palsy, and spinal cord injury1–3. |
| PubMedID- 20831013 | Background: spasticity in patients with infantile cerebral palsy may lead to progressive subluxation and/or hip dislocation. |
| PubMedID- 20655641 | The aim of this study is to examine the relationship between gait efficiency, gait kinematics, lower limb muscle strength, and muscular spasticity in adolescents with cerebral palsy. |
| PubMedID- 21540003 | Pharmacotherapy of spasticity in children with cerebral palsy. |
| PubMedID- 23967895 | To manage spasticity in children with spastic cerebral palsy botulinum toxin type-a (btx-a) injected by manual intramuscular needle placement in the lower extremity under general anaesthesia is an established treatment and standard of care in children with spastic cp [3-6]. |
| PubMedID- 24432099 | Objectives: in the last 2 decades, btx-a is increasingly being used in the management of spasticity in children with cerebral palsy (cp) and there is no doubt about its effect on range of motion, spasticity reduction and gait pattern in this patient population. |
| PubMedID- 24348041 | In this context, results of this study suggest that specific cerebellar stimulation may influence highly decreased information transference measured by pti between left and right autonomic neural activities, reflecting brain left and right ipsilateral modulatory influences, and may specifically influence spastic symptoms in cerebral palsy, leading to decreased spasticity and relaxed state. |
| PubMedID- 25803254 | Objective: the aim of this study was to determine the efficacy of semitendinosus and gastrocnemius tenotomies on popliteal angle presenting knee flexion spasticity in children with cerebral palsy (cp). |
| PubMedID- 23218728 | A clinical measurement to quantify spasticity in children with cerebral palsy by integration of multidimensional signals. |
| PubMedID- 25171568 | Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy. |
| PubMedID- 20298838 | Relationship between age and spasticity in children with diplegic cerebral palsy. |
| PubMedID- 20946685 | Improvements from wbv exercise have been reported in muscle function (strength [2,29-33], power [2,32], velocity [32]), balance [29,34-37], a reduction of muscle spasticity in those with cerebral palsy [38], and postural control in those with parkinson's disease [39]. |
| PubMedID- 25087164 | The subsequent clinical picture was dominated by impaired physical growth and a very consistent pattern of static cerebral palsy-like encephalopathy with spasticity and severe to profound mental retardation seen in over 80% of cases. |
| PubMedID- 23346608 Management of Spasticity and Co-Existing Motor Disorders and Their Early Musculoskeletal Complications | The guideline covers the management of spasticity associated with cerebral palsy, but not all aspects of the management of cerebral palsy. |
| PubMedID- 26077594 | Purpose: selective dorsal rhizotomy (sdr) is a neurosurgical procedure used to treat spasticity in children with cerebral palsy (cp). |
| PubMedID- 21206767 | The posterior root section for treatment of spasticity in cerebral palsy and diluted procaine injection near intramuscular nerve for treating hyperactive stretch reflex (rushworth, 1960) were based on this theory. |
| PubMedID- 24954890 | Background: one of the treatment option to reduce spasticity in cerebral palsy children is selective dorsal rhizotomy. |
| PubMedID- 20430330 | The use of botulinum toxins to decrease spasticity in children with cerebral palsy has become standard of care during the past decade. |
| PubMedID- 22659636 | Objective: the aim of this study was to analyze the intraobserver reliability of the modified ashworth scale (mas) and modified tardieu scale (mts) in the assessment of spasticity in children with cerebral palsy (cp). |
| PubMedID- 25516151 | Quadriceps femoris spasticity in children with cerebral palsy: measurement with the pendulum test and relationship with gait abnormalities. |
| PubMedID- 22851256 | Updates in the treatment of spasticity associated with cerebral palsy. |
| PubMedID- 25536713 | Reduction of spasticity in cerebral palsy by anodal transcranial direct current stimulation. |
| PubMedID- 25084089 | Intrathecal baclofen (itb) is a reversible treatment that reduces muscle tone to ameliorate spasticity and dystonia in patients with cerebral palsy (cp). |
| PubMedID- 22837977 | The precise quantification of spasticity in cerebral palsy (cp) is important in order to establish the effectiveness of medical and physical therapeutic interventions. |
| PubMedID- 21087238 | Interpretation: the outcomes of neuronox, based on prs, proved to be as effective and safe as those of botox for the treatment of spasticity in individuals with cerebral palsy. |
| PubMedID- 21102209 | Background: crouch gait in cerebral palsy is associated with spasticity and contracture of the hamstrings and weakness of the extensors of the hip and knee and ankle plantar flexors. |
| PubMedID- 20633177 | Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement. |
| PubMedID- 20493744 | In the last few years botulinum toxin type a (btx-a) has been widely used in the management of spasticity in children with cerebral palsy in order to reduce hypertonicity and improve functional outcomes enhancing motor skill development. |
| PubMedID- 25846806 | Reliability and validity of the duncan-ely test for assessing rectus femoris spasticity in patients with cerebral palsy. |
| PubMedID- 24175866 | Selective dorsal rhizotomy for spasticity not associated with cerebral palsy: reconsideration of surgical inclusion criteria. |
| PubMedID- 20121371 | Object: intrathecal baclofen is an effective treatment for spasticity in patients with cerebral palsy. |
| PubMedID- 25200577 | Functional posterior rhizotomy, mostly used to treat paraplegic spasticity in children with cerebral palsy, involves the sectioning of posterior rootlets associated with abnormal motor responses to electrical stimulation. |
| PubMedID- 23039838 | Object: intrathecal baclofen therapy has been used successfully for intractable spasticity in children with cerebral palsy. |
Page: 1 2